List of Tables
Table 1. Global Cystic Fibrosis Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of CFTR
Table 3. Key Players of Mucolytics
Table 4. Key Players of PERT
Table 5. Key Players of Anti-infectives
Table 6. Key Players of Bronchodilators
Table 7. Global Cystic Fibrosis Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Cystic Fibrosis Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Cystic Fibrosis Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Cystic Fibrosis Therapeutics Market Share by Region (2017-2022)
Table 11. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Cystic Fibrosis Therapeutics Market Share by Region (2023-2028)
Table 13. Cystic Fibrosis Therapeutics Market Trends
Table 14. Cystic Fibrosis Therapeutics Market Drivers
Table 15. Cystic Fibrosis Therapeutics Market Challenges
Table 16. Cystic Fibrosis Therapeutics Market Restraints
Table 17. Global Cystic Fibrosis Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Cystic Fibrosis Therapeutics Revenue Share by Players (2017-2022)
Table 19. Global Top Cystic Fibrosis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis Therapeutics as of 2021)
Table 20. Ranking of Global Top Cystic Fibrosis Therapeutics Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Cystic Fibrosis Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cystic Fibrosis Therapeutics Product Solution and Service
Table 24. Date of Enter into Cystic Fibrosis Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cystic Fibrosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Cystic Fibrosis Therapeutics Revenue Market Share by Type (2017-2022)
Table 28. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Cystic Fibrosis Therapeutics Revenue Market Share by Type (2023-2028)
Table 30. Global Cystic Fibrosis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Cystic Fibrosis Therapeutics Revenue Share by Application (2017-2022)
Table 32. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Cystic Fibrosis Therapeutics Revenue Share by Application (2023-2028)
Table 34. North America Cystic Fibrosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Cystic Fibrosis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Cystic Fibrosis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Cystic Fibrosis Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Cystic Fibrosis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Cystic Fibrosis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Cystic Fibrosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Cystic Fibrosis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Cystic Fibrosis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Cystic Fibrosis Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Cystic Fibrosis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Cystic Fibrosis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Cystic Fibrosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Cystic Fibrosis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Cystic Fibrosis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Cystic Fibrosis Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Cystic Fibrosis Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Cystic Fibrosis Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Cystic Fibrosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Cystic Fibrosis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Cystic Fibrosis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Cystic Fibrosis Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Cystic Fibrosis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Cystic Fibrosis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Cystic Fibrosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Cystic Fibrosis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Cystic Fibrosis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Cystic Fibrosis Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Cystic Fibrosis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Cystic Fibrosis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 64. Vertex Pharmaceuticals Company Details
Table 65. Vertex Pharmaceuticals Business Overview
Table 66. Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Product
Table 67. Vertex Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
Table 68. Vertex Pharmaceuticals Recent Developments
Table 69. F. Hoffmann-La Roche Company Details
Table 70. F. Hoffmann-La Roche Business Overview
Table 71. F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Product
Table 72. F. Hoffmann-La Roche Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
Table 73. F. Hoffmann-La Roche Recent Developments
Table 74. AbbVie Company Details
Table 75. AbbVie Business Overview
Table 76. AbbVie Cystic Fibrosis Therapeutics Product
Table 77. AbbVie Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
Table 78. AbbVie Recent Developments
Table 79. Gilead Sciences Company Details
Table 80. Gilead Sciences Business Overview
Table 81. Gilead Sciences Cystic Fibrosis Therapeutics Product
Table 82. Gilead Sciences Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
Table 83. Gilead Sciences Recent Developments
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Cystic Fibrosis Therapeutics Product
Table 87. Novartis Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
Table 88. Novartis Recent Developments
Table 89. AstraZeneca Company Details
Table 90. AstraZeneca Business Overview
Table 91. AstraZeneca Cystic Fibrosis Therapeutics Product
Table 92. AstraZeneca Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
Table 93. AstraZeneca Recent Developments
Table 94. Bayer Company Details
Table 95. Bayer Business Overview
Table 96. Bayer Cystic Fibrosis Therapeutics Product
Table 97. Bayer Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
Table 98. Bayer Recent Developments
Table 99. Celtaxsys Company Details
Table 100. Celtaxsys Business Overview
Table 101. Celtaxsys Cystic Fibrosis Therapeutics Product
Table 102. Celtaxsys Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
Table 103. Celtaxsys Recent Developments
Table 104. Pharmaxis Company Details
Table 105. Pharmaxis Business Overview
Table 106. Pharmaxis Cystic Fibrosis Therapeutics Product
Table 107. Pharmaxis Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
Table 108. Pharmaxis Recent Developments
Table 109. ProQR Therapeutics Company Details
Table 110. ProQR Therapeutics Business Overview
Table 111. ProQR Therapeutics Cystic Fibrosis Therapeutics Product
Table 112. ProQR Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
Table 113. ProQR Therapeutics Recent Developments
Table 114. PTC Therapeutics Company Details
Table 115. PTC Therapeutics Business Overview
Table 116. PTC Therapeutics Cystic Fibrosis Therapeutics Product
Table 117. PTC Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
Table 118. PTC Therapeutics Recent Developments
Table 119. Alcresta Therapeutics Company Details
Table 120. Alcresta Therapeutics Business Overview
Table 121. Alcresta Therapeutics Cystic Fibrosis Therapeutics Product
Table 122. Alcresta Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
Table 123. Alcresta Therapeutics Recent Developments
Table 124. Insmed Incorporated Company Details
Table 125. Insmed Incorporated Business Overview
Table 126. Insmed Incorporated Cystic Fibrosis Therapeutics Product
Table 127. Insmed Incorporated Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
Table 128. Insmed Incorporated Recent Developments
Table 129. Savara Company Details
Table 130. Savara Business Overview
Table 131. Savara Cystic Fibrosis Therapeutics Product
Table 132. Savara Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
Table 133. Savara Recent Developments
Table 134. Cyclacel Pharmaceuticals Company Details
Table 135. Cyclacel Pharmaceuticals Business Overview
Table 136. Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Product
Table 137. Cyclacel Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
Table 138. Cyclacel Pharmaceuticals Recent Developments
Table 139. Vectura Company Details
Table 140. Vectura Business Overview
Table 141. Vectura Cystic Fibrosis Therapeutics Product
Table 142. Vectura Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
Table 143. Vectura Recent Developments
Table 144. Allergan Company Details
Table 145. Allergan Business Overview
Table 146. Allergan Cystic Fibrosis Therapeutics Product
Table 147. Allergan Revenue in Cystic Fibrosis Therapeutics Business (2017-2022) & (US$ Million)
Table 148. Allergan Recent Developments
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cystic Fibrosis Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. CFTR Features
Figure 3. Mucolytics Features
Figure 4. PERT Features
Figure 5. Anti-infectives Features
Figure 6. Bronchodilators Features
Figure 7. Global Cystic Fibrosis Therapeutics Market Share by Application: 2021 VS 2028
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Cystic Fibrosis Therapeutics Report Years Considered
Figure 11. Global Cystic Fibrosis Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Cystic Fibrosis Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Cystic Fibrosis Therapeutics Market Share by Region: 2021 VS 2028
Figure 14. Global Cystic Fibrosis Therapeutics Market Share by Players in 2021
Figure 15. Global Top Cystic Fibrosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis Therapeutics as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Cystic Fibrosis Therapeutics Revenue in 2021
Figure 17. North America Cystic Fibrosis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Cystic Fibrosis Therapeutics Market Size Market Share by Type (2017-2028)
Figure 19. North America Cystic Fibrosis Therapeutics Market Size Market Share by Application (2017-2028)
Figure 20. North America Cystic Fibrosis Therapeutics Market Size Share by Country (2017-2028)
Figure 21. United States Cystic Fibrosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Cystic Fibrosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Cystic Fibrosis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Cystic Fibrosis Therapeutics Market Size Market Share by Type (2017-2028)
Figure 25. Europe Cystic Fibrosis Therapeutics Market Size Market Share by Application (2017-2028)
Figure 26. Europe Cystic Fibrosis Therapeutics Market Size Share by Country (2017-2028)
Figure 27. Germany Cystic Fibrosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Cystic Fibrosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Cystic Fibrosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Cystic Fibrosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Cystic Fibrosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Cystic Fibrosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Cystic Fibrosis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Cystic Fibrosis Therapeutics Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Cystic Fibrosis Therapeutics Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Cystic Fibrosis Therapeutics Market Size Share by Region (2017-2028)
Figure 37. China Cystic Fibrosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Cystic Fibrosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Cystic Fibrosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Cystic Fibrosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Cystic Fibrosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Cystic Fibrosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Cystic Fibrosis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Cystic Fibrosis Therapeutics Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Cystic Fibrosis Therapeutics Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Cystic Fibrosis Therapeutics Market Size Share by Country (2017-2028)
Figure 47. Mexico Cystic Fibrosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Cystic Fibrosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Cystic Fibrosis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Cystic Fibrosis Therapeutics Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Cystic Fibrosis Therapeutics Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Cystic Fibrosis Therapeutics Market Size Share by Country (2017-2028)
Figure 53. Turkey Cystic Fibrosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Cystic Fibrosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Cystic Fibrosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Vertex Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
Figure 57. F. Hoffmann-La Roche Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
Figure 58. AbbVie Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
Figure 59. Gilead Sciences Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
Figure 60. Novartis Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
Figure 61. AstraZeneca Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
Figure 62. Bayer Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
Figure 63. Celtaxsys Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
Figure 64. Pharmaxis Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
Figure 65. ProQR Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
Figure 66. PTC Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
Figure 67. Alcresta Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
Figure 68. Insmed Incorporated Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
Figure 69. Savara Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
Figure 70. Cyclacel Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
Figure 71. Vectura Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
Figure 72. Allergan Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2017-2022)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
